about
Organotypic Cultures as a Model to Study Adult Neurogenesis in CNS DisordersPío del Río Hortega and the discovery of the oligodendrocytesDifferential neuroprotective effects of 5'-deoxy-5'-methylthioadenosineNeuronal Hyperactivity Disturbs ATP Microgradients, Impairs Microglial Motility, and Reduces Phagocytic Receptor Expression Triggering Apoptosis/Microglial Phagocytosis UncouplingA model of ischemia-induced neuroblast activation in the adult subventricular zoneClozapine reduces GLT-1 expression and glutamate uptake in astrocyte culturesIncreased expression and function of glutamate transporters in multiple sclerosisDual-specific phosphatase-6 (Dusp6) and ERK mediate AMPA receptor-induced oligodendrocyte deathInhibition of cyclin-dependent kinases is neuroprotective in 1-methyl-4-phenylpyridinium-induced apoptosis in neuronsDevelopment of a new family of conformationally restricted peptides as potent nucleators of beta-turns. Design, synthesis, structure, and biological evaluation of a beta-lactam peptide analogue of melanostatin.Cloning and expression of a P2y purinoceptor from the adult bovine corpus callosum.Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia.Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions.Role of monoubiquitylation on the control of IκBα degradation and NF-κB activityPlasma brain-derived neurotrophic factor levels, learning capacity and cognition in patients with first episode psychosis.Excitotoxicity in glial cells.Pharmacogenomics of the response to IFN-beta in multiple sclerosis: ramifications from the first genome-wide screen.Increased expression of cystine/glutamate antiporter in multiple sclerosisSubclinical depressive symptoms and continued cannabis use: predictors of negative outcomes in first episode psychosisBlockade of P2X7 receptors or pannexin-1 channels similarly attenuates postischemic damage.Neuroprotection by tetracyclines.Therapeutic potential of kainate receptors.Calcium and glial cell death.Glutamate-mediated glial injury: mechanisms and clinical importance.BDNF and NGF Signalling in Early Phases of Psychosis: Relationship With Inflammation and Response to Antipsychotics After 1 Year.1-42 β-amyloid peptide requires PDK1/nPKC/Rac 1 pathway to induce neuronal death.Excitotoxic damage to white matter.Synaptic plasticity and spatial working memory are impaired in the CD mouse model of Williams-Beuren syndrome.PET Imaging with [(18)F]FSPG Evidences the Role of System xc(-) on Brain Inflammation Following Cerebral Ischemia in Rats.Neuroglial interactions mediated by purinergic signalling in the pathophysiology of CNS disorders.Protecting white matter from stroke injury.Neurotransmitter signaling in the pathophysiology of microglia.Neurotransmitter signaling in white matter.White matter injury: Ischemic and nonischemic.ATP signaling in brain: release, excitotoxicity and potential therapeutic targets.Adenosine A1 receptor inhibits postnatal neurogenesis and sustains astrogliogenesis from the subventricular zone.Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis.A novel alternative splicing form of excitatory amino acid transporter 1 is a negative regulator of glutamate uptake.FTY720 attenuates excitotoxicity and neuroinflammation.A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis.
P50
Q26749034-C81340AB-4EF7-4C65-A84D-F873BC3167D6Q26798880-45BF0968-69B2-4A5C-B363-3C961CF15EBFQ27317185-F503DD26-1DF1-4139-AD08-DE7377F58CC9Q27342713-E1E719E3-6558-4BB2-96D5-81E89FE25066Q27349769-CD22BF9A-69B5-448D-9AFE-7E7616E78BBFQ28237457-3B5F3D86-4423-4B91-838F-6CDDA926C933Q28265070-C4594BCB-F2F4-4A5A-A63B-68C21E124B18Q28566860-47F5F54F-4140-40D5-A9BA-B74A0FEF2194Q28580633-B60EF7E8-9992-4E4A-AEC6-C16995260501Q30886679-E21833C7-9850-4A00-87CC-709C7934502BQ31957566-74FAFFCC-8413-4A7E-B081-54145F12B62FQ33956303-F7F79AFA-254D-42D9-8B3E-3269D92E71E8Q34025536-5F68C254-79F4-46A4-9DDE-0D68120C4F5BQ34055565-04A352D1-D403-497D-83B1-D36F1E4D4475Q34548501-E80C005C-F4B4-475D-A6F6-51B48EE5E262Q34768751-A5966C5D-B6B3-4825-A777-5594F13AC584Q34777373-87B22909-E556-4B98-817D-B60AA1E29082Q35052754-9E9F1F78-029E-4BD0-8FBE-8B796345D8AEQ35431667-1172E725-77BB-4C14-A96C-B1C9B6F3F60CQ35572808-13CCEC48-4551-428D-906B-2A2133273BB7Q35941699-6F74FDA5-9796-4EE6-88BB-D806A946346AQ36199193-A4DB703D-29F2-4742-BA13-775C935D3545Q36226561-24B747D0-2588-49A8-9E16-E0B114A93D02Q36277315-BDC0561F-4791-47EE-93A3-6393B6BB7E80Q36377832-949F055E-E955-4A1D-9EF0-C860E4FF8BEEQ36593861-05A59B97-770F-4403-B3AC-91B3A7E8C0EEQ36822954-C1E61E71-7E22-42CD-838A-B69187F4E941Q37148526-2738AA9C-D834-46AB-8ACB-CF92A1F3DC0FQ37202278-9C32788D-A37A-43C1-A23C-BB07AC918D69Q37841843-4C3D8051-8FBE-4A3F-B205-994ECB75A57BQ38065070-C851511A-80C7-4EA6-BB01-ED97C29D2188Q38102686-D0103B50-EBF3-404C-B643-81242657CE7BQ38206164-870986E3-B1A3-48F0-8B11-1EDDB9C23635Q38231843-E8F0CE92-F387-4884-8A7E-CECFE9D6A9EBQ38237280-94D01A1B-3A00-42DB-83F0-CD18F4E36C50Q39683996-A05A5E23-C1A1-4F6F-B518-A973F6CEEF6CQ39996819-89EAAFB6-72ED-4BCC-BFAA-C60623277848Q40393535-64C9C337-248E-4EC6-9FC1-789A177309E0Q40613316-3D71CB7B-8DA3-4369-BEC0-87C1C1826827Q40722405-36E3D982-7B98-484D-A9FA-49F1CDCAEF4F
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Carlos Matute
@ast
Carlos Matute
@en
Carlos Matute
@es
Carlos Matute
@nl
Carlos Matute
@sl
type
label
Carlos Matute
@ast
Carlos Matute
@en
Carlos Matute
@es
Carlos Matute
@nl
Carlos Matute
@sl
prefLabel
Carlos Matute
@ast
Carlos Matute
@en
Carlos Matute
@es
Carlos Matute
@nl
Carlos Matute
@sl
P106
P21
P31
P496
0000-0001-8672-711X
P5463
Matute_Carlos